Korean Drug Co., Ltd. (KOSDAQ:014570)

Korean Drug Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 5, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	43,102	50,141	78,348	85,441	97,444	112,394
Market Cap Growth	-18.39%	-36.00%	-8.30%	-12.32%	-13.30%	43.25%
Enterprise Value	14,149	30,087	41,605	53,950	71,749	92,548
Last Close Price	3950.00	4405.30	6649.24	7098.22	7914.17	8954.36
PE Ratio	15.44	16.74	-	7.24	10.78	15.27
PS Ratio	0.69	0.69	0.96	1.07	1.31	1.68
PB Ratio	0.53	0.64	1.02	1.01	1.27	1.59
P/TBV Ratio	0.53	0.64	1.02	1.01	1.27	1.60
P/FCF Ratio	4.12	13.05	-	-	12.72	9.70
P/OCF Ratio	3.95	10.30	-	14.45	11.07	9.12
EV/Sales Ratio	0.23	0.41	0.51	0.68	0.96	1.39
EV/EBITDA Ratio	3.20	4.87	4.91	3.43	5.63	7.47
EV/EBIT Ratio	5.81	7.33	6.19	3.77	6.37	8.38
EV/FCF Ratio	1.35	7.83	-	-	9.37	7.98
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.00	0.00
Debt / EBITDA Ratio	0.02	0.01	0.01	0.01	0.00	0.00
Debt / FCF Ratio	0.01	0.02	-	-	0.01	0.00
Net Debt / Equity Ratio	-0.36	-0.24	-0.22	-0.31	-0.36	-0.31
Net Debt / EBITDA Ratio	-6.54	-3.06	-1.97	-1.68	-2.18	-1.79
Net Debt / FCF Ratio	-2.76	-4.92	7.88	146.19	-3.63	-1.91
Asset Turnover	0.66	0.82	0.88	0.87	0.87	0.84
Inventory Turnover	1.77	2.01	2.74	3.41	3.67	3.37
Quick Ratio	5.34	5.81	4.52	7.81	5.51	5.13
Current Ratio	7.25	8.73	6.41	9.80	6.82	6.44
Return on Equity (ROE)	3.43%	3.86%	-6.08%	14.63%	12.26%	10.83%
Return on Assets (ROA)	1.61%	2.87%	4.56%	9.78%	8.19%	8.67%
Return on Invested Capital (ROIC)	3.77%	4.12%	-6.73%	21.49%	18.45%	17.19%
Return on Capital Employed (ROCE)	2.90%	5.00%	8.40%	16.50%	14.40%	15.00%
Earnings Yield	6.42%	5.97%	-6.28%	13.82%	9.28%	6.55%
FCF Yield	24.29%	7.66%	-2.71%	-0.21%	7.86%	10.31%
Payout Ratio	62.55%	54.02%	-	15.52%	18.07%	14.80%
Buyback Yield / Dilution	-0.30%	-0.08%	0.01%	1.30%	-0.56%	0.33%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.